封面
市場調查報告書
商品編碼
1542413

全球心律管理設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Cardiac Rhythm Management Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

全球心律管理設備市場需求預計將從 2023 年的 224.1 億美元達到近 405.8 億美元的市場規模,2024-2032 年研究期間複合年成長率為 6.82%。

心律管理 (CRM) 設備可監測、診斷和治療不規則心律或心律不整。這些設備包括心律調節器、植入式心律轉復除顫器 (ICD) 和心臟再同步治療 (CRT) 設備。心律調節器可幫助調節心律緩慢或不規則患者的心跳,而 ICD 則提供電擊以糾正危及生命的心律不整。 CRT 設備可提高心臟衰竭患者的心臟泵血效率。 CRM 設備對於管理各種心臟疾病、改善患者治療效果以及提高心律不整患者的生活品質至關重要。

市場動態

心律不整和心臟衰竭的盛行率日益增加,推動了心律管理設備市場的發展,因此需要先進的管理解決方案。 CRM 設備的技術進步(例如小型化和遠端監控系統)為改善病患照護和便利性創造了新的機會。人口老化的擴大和心臟健康意識的提高進一步推動了市場的成長。新興市場醫療保健基礎設施的擴大和先進醫療技術的普及也帶來了機會。 CRM 設備技術的創新,包括延長電池壽命和資料分析功能,有助於市場擴張並改善患者治療效果。然而,高昂的設備成本和監管挑戰可能會限制心律管理設備市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球心律管理設備市場的各個細分市場進行了包容性評估。心律管理設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心律管理設備市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 心律調節器(植入式、體外式)
  • 除顫器(植入式心臟復律去顫器(ICD)(S-ICD、T-ICD)、體外去顫器(手動體外去顫器、自動體外去顫器、穿戴式心臟復律去顫器))
  • 心臟再同步治療 (CRT)(CRT-去顫器、CRT-心律調節器)

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的心律管理設備市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心律管理設備市場的主要參與者包括 Physio-Control Inc.、Medtronic Plc、Abbott、Boston Scientific Corporation、Schiller、Koninklijke Philips NV、BIOTRONIK、Progetti Srl、Zoll Medical Corporation 和 LivaNova Plc。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:心律管理設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球心律管理設備市場分析:依產品

  • 概述(按產品)
  • 按產品分類的歷史和預測資料分析
  • 心律調節器(植入式、體外式)
  • 除顫器(植入式心臟復律去顫器(ICD)(S-ICD、T-ICD)、體外去顫器(手動體外去顫器、自動體外去顫器、穿戴式式心臟復律去顫器))
  • 心臟再同步治療 (CRT)(CRT-去顫器、CRT-心律調節器)

第 6 章:全球心律管理設備市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 7 章:心律管理設備公司的競爭格局

  • 心律管理設備市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 8 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Physio-Control Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Medtronic Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Boston Scientific Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Schiller
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Koninklijke Philips NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BIOTRONIK
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Progetti Srl
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Zoll Medical Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • LivaNova Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資訊和最新發展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR11218634

The global demand for Cardiac Rhythm Management Devices Market is presumed to reach the market size of nearly USD 40.58 Billion by 2032 from USD 22.41 Billion in 2023 with a CAGR of 6.82% under the study period 2024-2032.

Cardiac rhythm management (CRM) devices monitor, diagnose, and treat irregular heart rhythms or arrhythmias. These devices include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Pacemakers help regulate heartbeats in patients with slow or irregular heart rhythms, while ICDs provide shocks to correct life-threatening arrhythmias. CRT devices improve the heart's pumping efficiency in patients with heart failure. CRM devices are crucial for managing various cardiac conditions, improving patient outcomes, and enhancing the quality of life for individuals with heart rhythm disorders.

MARKET DYNAMICS

The cardiac rhythm management devices market is driven by the increasing prevalence of cardiac arrhythmias and heart failure, necessitating advanced management solutions. Technological advancements in CRM devices, such as miniaturized and remote monitoring systems, create new opportunities for improved patient care and convenience. The expanding aging population and rising awareness about heart health further fuel market growth. Opportunities also arise from expanding healthcare infrastructure and increasing access to advanced medical technologies in emerging markets. Innovations in CRM device technologies, including enhanced battery life and data analytics capabilities, contribute to market expansion and improved patient outcomes. However, high device costs and regulatory challenges may restrain the growth of the cardiac rhythm management devices market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Rhythm Management Devices. The growth and trends of Cardiac Rhythm Management Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Rhythm Management Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Pacemakers (Implantable, External)
  • Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator))
  • Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Rhythm Management Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Rhythm Management Devices market include Physio-Control Inc., Medtronic Plc, Abbott, Boston Scientific Corporation, Schiller, Koninklijke Philips N.V., BIOTRONIK, Progetti Srl, Zoll Medical Corporation, LivaNova Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARDIAC RHYTHM MANAGEMENT DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Pacemakers (Implantable, External) Historic and Forecast Sales By Regions
  • 5.4. Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator)) Historic and Forecast Sales By Regions
  • 5.5. Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers) Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CARDIAC RHYTHM MANAGEMENT DEVICES COMPANIES

  • 7.1. Cardiac Rhythm Management Devices Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Physio-Control Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Medtronic Plc
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Abbott
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. Boston Scientific Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Schiller
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. Koninklijke Philips N.V.
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. BIOTRONIK
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments
  • 8.10. Progetti Srl
    • 8.10.1 Company Overview
    • 8.10.2 Company Revenue
    • 8.10.3 Products
    • 8.10.4 Recent Developments
  • 8.11. Zoll Medical Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Company Revenue
    • 8.11.3 Products
    • 8.11.4 Recent Developments
  • 8.12. LivaNova Plc
    • 8.12.1 Company Overview
    • 8.12.2 Company Revenue
    • 8.12.3 Products
    • 8.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Pacemakers (Implantable, External) Market Sales By Geography (USD MN)
  • Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator)) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers) Market Sales By Geography (USD MN)
  • Global Cardiac Rhythm Management Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cardiac Rhythm Management Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiac Rhythm Management Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Pacemakers (Implantable, External) Market Sales By Geography (USD MN)
  • Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator)) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.